Search Results - "Orczyk, C."

Assessment of change in prostate volume and shape following surgical resection through co-registration of in-vivo MRI and fresh specimen ex-vivo MRI by Orczyk, C, Taneja, S.S, Rusinek, H, Rosenkrantz, A.B

“…Aim To compare the size and shape of the prostate between in-vivo and fresh ex-vivo magnetic resonance imaging (MRI), in order to quantify alterations in the…”
Get full text

Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI by Orczyk, C, Rusinek, H, Rosenkrantz, A.B, Mikheev, A, Deng, F.-M, Melamed, J, Taneja, S.S

“…Aim To assess a novel method of three-dimensional (3D) co-registration of prostate cancer digital histology and in-vivo multiparametric magnetic resonance…”
Get full text

Is focal ablation as effective as hemi-ablation? Analysis of treatment patterns over 12 years from a high volume centre for focal therapy by Stabile, A., Gandaglia, G., Fossati, N., Sorce, G., Scuderi, S., Fallara, G., Cucchiara, V., Zaffuto, E., Robesti, D., Pellegrino, F., Orczyk, C., Giganti, F., Ahmed, H.U., Emberton, M., Briganti, A., Montorsi, F., Moore, C.M.

Get full text

Is focal ablation as effective as hemi-ablation? analysis of treatment patterns over 12 years from a high volume centre for focal therapy by Stabile, A., Gandaglia, G., Fossati, N., Gallina, A., Bravi, C.A., Mazzone, E., Martini, A., Barletta, F., Scuderi, S., Fallara, G., Cucchiara, V., Zaffuto, E., Daniele, R., Pellegrino, F., Orczyk, C., Giganti, F., Ahmed, H.U., Emberton, M., Briganti, A., Montorsi, F., Moore, C.M.

Get full text

The relationship between percentage PSA reduction and rate of failure after focal therapy for prostate cancer by Stabile, A., Gandaglia, G., Fossati, N., Orczyk, C., Giganti, F., Scuderi, S., Cucchiara, V., Robesti, D., Zaffuto, E., Barletta, F., Sorce, G., Pellegrino, F., Moschini, M., Cathala, N., Macek, P., Ahmed, H.U., Emberton, M., Cathelineau, X., Briganti, A., Montorsi, F., Sanchez-Salas, R., Moore, C.M.

Get full text

A new technique for ensuring negative surgical margins during partial nephrectomy: the ex vivo ultrasound control by Desmonts, A, Tillou, X, Le Gal, S, Secco, M, Orczyk, C, Bensadoun, H, Doerfler, A

“…To evaluate the feasibility and the efficiency of intraoperative ex vivo ultrasound of resection margins in patients undergoing partial nephrectomy by…”
Get more information

PO-1132 RCT evidence in 2018 ASTRO/ASCO/AUA guidelines for hypofractionated radiotherapy in prostate cancer by Williams, N., Orczyk, C.

Get full text

Emergency nephrectomies: retrospective monocentric study, about eight cases by Secco, M, Tillou, X, Desmonts, A, Orczyk, C, Le Gal, S, Bensadoun, H, Doerfler, A

“…Emergency nephrectomies are rare because of the improvement of the management of urinary tract infections and the development of radio-embolization. Few series…”
Get more information

Is local anaesthetic transperineal prostate biopsy feasible and acceptable: A comparison of patient experience under local anaesthetic or sedation by Valero Sarmiento, L., Marenco, J.L., Moore, C., Orczyk, C., Collins, T., Emberton, M.

Get full text

Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer: Defining a 3-Dimensional Treatment Margin Based on Magnetic Resonance Imaging Histology Co-Registration Analysis by Le Nobin, Julien, Rosenkrantz, Andrew B, Villers, Arnauld, Orczyk, Clément, Deng, Fang-Ming, Melamed, Jonathan, Mikheev, Artem, Rusinek, Henry, Taneja, Samir S

“…Purpose We compared prostate tumor boundaries on magnetic resonance imaging and radical prostatectomy histological assessment using detailed software assisted…”
Get full text

Prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: A systematic review and meta-analysis by Satish, P., Freeman, A., Kelly, D., Kirkham, A., Orczyk, C., Simpson, B., Giganti, F., Whitaker, H.C., Emberton, M., Norris, J.M.

Get full text

Focal HIFU and cryotherapy for prostate cancer: A HEAT and ICE analysis of 15-year usage trends in the United Kingdom by Light, A., Mayor, N., Cullen, E., Arya, M., Grey, A., Orczyk, C., Moore, C.M., Emberton, M., Dudderidge, T., Hindley, R., Emara, A., Noureldin, M., Nigam, R., Virdi, J., Laniado, M., Mccraken, S., Greene, D., Ahmed, H.U., Shah, T.T.

Get full text

A0672 - Focal HIFU and cryotherapy for prostate cancer: A HEAT and ICE analysis of 15-year usage trends in the United Kingdom by Light, A., Mayor, N., Cullen, E., Arya, M., Grey, A., Orczyk, C., Moore, C.M., Emberton, M., Dudderidge, T., Hindley, R., Emara, A., Noureldin, M., Nigam, R., Virdi, J., Laniado, M., Mccraken, S., Greene, D., Ahmed, H.U., Shah, T.T.

Get full text

Tumor characteristics of multiparametric MRI-detected and -undetected lesions in patients with suspected radiorecurrent prostate cancer: An analysis from the FOcal RECurrent Assessment and Salvage Treatment (FORECAST) trial by Light, A., Kanthabalan, A., Pavlou, M., Omar, R., Adeleke, S., Giganti, F., Brew-Graves, C., Emara, A., Haroon, A., Latifoltojar, A., Sidhu, H., Freeman, A., Orczyk, C., Nikapota, A., Dudderidge, T., Hindley, R.G., Payne, H., Mitra, A., Bomanji, J., Winkler, M., Horan, G., Punwani, S., Ahmed, H.U., Shah, T.T.

Get full text

A1245 - Tumor characteristics of multiparametric MRI-detected and -undetected lesions in patients with suspected radiorecurrent prostate cancer: An analysis from the FOcal RECurrent Assessment and Salvage Treatment (FORECAST) trial by Light, A., Kanthabalan, A., Pavlou, M., Omar, R., Adeleke, S., Giganti, F., Brew-Graves, C., Emara, A., Haroon, A., Latifoltojar, A., Sidhu, H., Freeman, A., Orczyk, C., Nikapota, A., Dudderidge, T., Hindley, R.G., Payne, H., Mitra, A., Bomanji, J., Winkler, M., Horan, G., Punwani, S., Ahmed, H.U., Shah, T.T.

Get full text

Primary focal cryotherapy for non-metastatic prostate cancer: Update from the UK ICE registry by Reddy, D.T., Peters, M., Shah, T., Van Son, M., Bertoncelli Tanaka, M., Huber, P., Lomas, D., Rakauskas, A., Miah, S., Eldred-Evans, D., Hosking-Jervis, F., Engle, R., Dudderidge, T., Mccracken, S., Greene, D., Nigam, R., Mccartan, N., Valerio, M., Orczyk, C., Virdi, J., Arya, M., Ahmed, H.

Get full text

Focal ablative salvage therapy for radio-recurrent prostate cancer: 6 year oncological and safety outcomes by Reddy, D.T., Peters, M., Shah, T., Van Son, M., Hosking-Jervis, F., Miah, S., Bertoncelli Tanaka, M., Eldred-Evans, D., Guillaumier, S., Huber, P., Lomas, D., Rakauskas, A., Dudderidge, T., Mccracken, S., Hindley, R., Emara, A., Nigam, R., Persad, R., Virdi, J., Moore, C., Orczyk, C., Emberton, M., Arya, M., Winkler, M., Ahmed, H.

Get full text

MRI and targeted biopsies compared to transperineal mapping biopsies for targeted ablation in recurrent prostate cancer after radiotherapy: Primary outcomes of the FORECAST trial by Shah, T.T., Kanthabalan, A., Pavlou, M., Adeleke, S., Giganti, F., Brew-Graves, C., Williams, N.R, Haroon, A., Sidhu, H., Freeman, A., Orczyk, C., Nikapota, A., Dudderidge, T., Hindley, R., Virdi, J., Arya, M., Mitra, A., Payne, H., Bomanji, J., Winkler, M., Horan, G., Moore, C., Emberton, M., Punwani, S., Ahmed, H.U

Get full text

Cancer control outcomes following focal therapy using HIFU in 1,829 men with non-metastatic prostate cancer treated over 15 years by Reddy, D.T., Peters, M., Shah, T., Van Son, M., Huber, P., Lomas, D., Rakauskas, A., Miah, S., Guillaumier, S., Dudderidge, T., Hindley, R., Emara, A., Nigam, R., Valerio, M., Afzal, N., Lewi, H., Orczyk, C., Ogden, C., Persad, R., Virdi, J., Moore, C., Arya, M., Winkler, M., Emberton, M., Ahmed, H.

Get full text

Late Toxicity and Patient Reported Outcomes in Patients Treated With Salvage Radiation Following Primary High Intensity Focal Ultrasound for Localized Prostate Cancer by Davda, R., Prentice, M., Sarova, A., Nei, W., Orczyk, C., Arya, M., Moore, C., Ahmed, H., Emberton, M., Mitra, A., Payne, H.

Get full text